Online citations, reference lists, and bibliographies.
← Back to Search

Synthesis And Biological Characterization Of Arylomycin B Antibiotics.

T. Roberts, P. A. Smith, F. Romesberg
Published 2011 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Antibiotics are virtually always isolated as families of related compounds, but the evolutionary forces underlying the observed diversity are generally poorly understood, and it is not even clear whether they are all expected to be biologically active. The arylomycin class of antibiotics is comprised of three related families that are differentiated by nitration, glycosylation, and hydroxylation of a conserved core scaffold. Previously, we reported the total synthesis of an A series member, arylomycin A2, as well as the A series derivative arylomycin C16 and showed that both are active against a broader spectrum of bacteria than previously appreciated. We now report the total synthesis of a B series analogue, arylomycin B-C16, and its aromatic amine derivative. While the aromatic amine loses activity against all bacteria tested, the B series compound shows activities that are similar to the A series compounds, except that it also gains activity against the important pathogen Streptococcus agalactiae.
This paper references
10.1128/JB.180.7.1939-1943.1998
Functions encoded by pyrrolnitrin biosynthetic genes from Pseudomonas fluorescens.
S. Kirner (1998)
10.1021/JO00013A037
Influence of ion pairing, steric effects, and other specific interactions on the reactivity of thioanions with chloronitrobenzenes. Nucleophilic aromatic substitution vs. reduction
S. Montanari (1991)
10.1099/00221287-147-10-2817
The gene cluster for chloramphenicol biosynthesis in Streptomyces venezuelae ISP5230 includes novel shikimate pathway homologues and a monomodular non-ribosomal peptide synthetase gene.
J. He (2001)
10.1021/NP50066A001
Why are secondary metabolites (natural products) biosynthesized?
D. Williams (1989)
10.1016/J.MIB.2007.08.009
Expanding the soil antibiotic resistome: exploring environmental diversity.
Vanessa M D'Costa (2007)
Prevention of group B streptococcal disease in the newborn.
B. Apgar (2005)
10.1111/j.1462-2920.2009.02125.x
Coevolution of antibiotic production and counter-resistance in soil bacteria.
Paris Laskaris (2010)
10.1021/JO981889T
Pathways of Nitrosobenzene Reduction by Thiols in Alcoholic Media.
S. Montanari (1999)
10.1002/chem.201000924
Intramolecular Suzuki-Miyaura reaction for the total synthesis of signal peptidase inhibitors, arylomycins A(2) and B(2).
Jérémy Dufour (2010)
10.1039/B208815K
Natural products--a simple model to explain chemical diversity.
R. Firn (2003)
10.1021/JA073340U
Structural and initial biological analysis of synthetic arylomycin A2.
T. Roberts (2007)
10.1074/JBC.M401686200
Crystallographic and Biophysical Analysis of a Bacterial Signal Peptidase in Complex with a Lipopeptide-based Inhibitor*
M. Paetzel (2004)
10.1002/cbic.200700042
Biosynthesis of Nitro Compounds
Robert Winkler (2007)
10.1073/pnas.0702207104
The frailty of adaptive hypotheses for the origins of organismal complexity
M. Lynch (2007)
10.1073/pnas.012399899
Chemical warfare between microbes promotes biodiversity
T. Czárán (2002)
10.1002/ANIE.199403521
The Biosynthesis of Nitro Compounds: The Enzymatic Oxidation to Pyrrolnitrin of Its Amino‐Substituted Precursor
S. Kirner (1994)
10.1098/rspb.2009.0320
The role of natural environments in the evolution of resistance traits in pathogenic bacteria
J. Martínez (2009)
10.1016/S0040-4039(00)88533-0
The biosynthesis of the pseudomonas antibiotic obafluorin from p-aminophenylalanine and glycine (glyoxylate)
R. Herbert (1990)
10.1038/NCHEMBIO0707-353
One pathway, many products.
M. Fischbach (2007)
10.1021/AR980015Q
From Tars to Products: How To Disentangle the Reactions of Nitrobenzenes with Nucleophiles
C. Paradisi (1999)
10.7164/ANTIBIOTICS.55.565
Arylomycins A and B, new biaryl-bridged lipopeptide antibiotics produced by Streptomyces sp. Tü 6075. I. Taxonomy, fermentation, isolation and biological activities.
J. Schimana (2002)
10.1246/CL.1987.2109
Iodination of Phenols by Use of Benzyltrimethylammonium Dichloroiodate(1
S. Kajigaeshi (1987)
10.1021/JA039328T
Biosynthetic origin of the rare nitroaryl moiety of the polyketide antibiotic aureothin: involvement of an unprecedented N-oxygenase.
Jing He (2004)
10.1038/nrmicro2312
Call of the wild: antibiotic resistance genes in natural environments
H. Allen (2010)
10.7164/ANTIBIOTICS.55.571
Arylomycins A and B, new biaryl-bridged lipopeptide antibiotics produced by Streptomyces sp. Tü 6075. II. Structure elucidation.
A. Hoeltzel (2002)
10.1074/JBC.M405884200
Novel Lipoglycopeptides as Inhibitors of Bacterial Signal Peptidase I*
P. Kulanthaivel (2004)
10.1007/s10295-005-0077-9
Marcel Faber Roundtable: Is our antibiotic pipeline unproductive because of starvation, constipation or lack of inspiration?
R. Baltz (2005)
10.1046/j.1365-2958.2000.02098.x
The evolution of secondary metabolism – a unifying model
R. Firn (2000)
10.1021/JA003835I
First and second generation total synthesis of the teicoplanin aglycon.
D. Boger (2001)
10.1073/pnas.0712073105
In vitro reconstitution and crystal structure of p-aminobenzoate N-oxygenase (AurF) involved in aureothin biosynthesis
Yoo Seong Choi (2008)
10.1128/MMBR.00006-10
Nitroaromatic Compounds, from Synthesis to Biodegradation
Kou-San Ju (2010)
10.1111/j.1365-2958.1992.tb00834.x
On the evolution of functional secondary metabolites (natural products)
M. J. Stone (1992)
10.1016/j.chembiol.2010.09.009
Broad-spectrum antibiotic activity of the arylomycin natural products is masked by natural target mutations.
P. A. Smith (2010)



This paper is referenced by
10.1002/anie.201208344
Nonproteinogenic amino acid building blocks for nonribosomal peptide and hybrid polyketide scaffolds.
C. Walsh (2013)
10.1016/j.bmc.2016.09.014
New antibiotics from Nature's chemical inventory.
Timothy A. Wencewicz (2016)
10.1080/22311866.2018.1561327
Streptomyces spp from Black Pepper Rhizosphere: A Boundless Reservoir of Antimicrobial and Growth Promoting Metabolites
T. Anusree (2019)
10.1021/ja207318n
Synthesis and characterization of the arylomycin lipoglycopeptide antibiotics and the crystallographic analysis of their complex with signal peptidase.
J. Liu (2011)
10.1128/AAC.04597-14
A Putative Cro-Like Repressor Contributes to Arylomycin Resistance in Staphylococcus aureus
Arryn Craney (2015)
Chapter 7 Bacterial Signal Peptidases
M. Paetzel (2019)
10.1128/AAC.00181-15
Origins of Yersinia pestis Sensitivity to the Arylomycin Antibiotics and the Inhibition of Type I Signal Peptidase
Danielle B. Steed (2015)
10.1515/znc-2016-0156
Structural diversity in echinocandin biosynthesis: the impact of oxidation steps and approaches toward an evolutionary explanation
Wolfgang Hüttel (2017)
10.1042/EBC20160077
Polishing the tarnished silver bullet: the quest for new antibiotics
M. Blaskovich (2017)
10.1002/ANGE.201208344
Nichtproteinogene Aminosäurebausteine für Peptidgerüste aus nichtribosomalen Peptiden und hybriden Polyketiden
C. Walsh (2013)
10.1128/JB.00064-12
Type I signal peptidase and protein secretion in Staphylococcus aureus.
Mark A Schallenberger (2012)
10.1039/C2MD20043K
Latent antibiotics and the potential of the arylomycins for broad-spectrum antibacterial activity
Yun Xuan Tan (2012)
10.1002/pro.757
Signal peptidase I: Cleaving the way to mature proteins
Sarah M. Auclair (2012)
10.1007/978-3-030-18768-2_7
Bacterial Signal Peptidases.
M. Paetzel (2019)
10.1021/acsomega.0c03352
Solid-Phase Synthesis of Biaryl Cyclic Lipopeptides Derived from Arylomycins
Iteng Ng-Choi (2020)
10.1016/j.bbamcr.2013.12.003
Structure and mechanism of Escherichia coli type I signal peptidase.
M. Paetzel (2014)
10.1002/ange.201913305
Synthesis of Biaryl‐Bridged Cyclic Peptides via Catalytic Oxidative Cross‐Coupling Reactions
Mor Ben-Lulu (2020)
10.1039/c5np00025d
Structural aspects of phenylglycines, their biosynthesis and occurrence in peptide natural products.
Rashed S Al Toma (2015)
10.1016/J.BIOCONTROL.2013.06.001
Investigating the bioactivity of cells and cell-free extracts of Streptomyces griseus towards Fusarium oxysporum f. sp. cubense race 4
Fathima Ameena Zacky (2013)
10.1016/B978-0-12-382219-2.00776-6
SpsB Signal Peptidase
D. Harris (2013)
10.1016/J.MOLSTRUC.2012.10.039
Synthesis, characterization, and crystal structure of 2-iodo-3,4,5-trimethoxybenzoic acid
Iliyan Kolev (2013)
10.1128/AAC.00785-12
Mechanism of Action of the Arylomycin Antibiotics and Effects of Signal Peptidase I Inhibition
P. Smith (2012)
10.1039/c2np20034a
Strained cyclophane natural products: macrocyclization at its limits.
Tanja Gulder (2012)
Semantic Scholar Logo Some data provided by SemanticScholar